Browse result page of THPdb

The total number entries retrieved from this search are 10

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1098	ThPPIDTh1014	NameSalmon Calcitonin	Peptide SequenceCSNLSTCVLGKLSQELHKLQ Full view	Length32	Functional ClassificationIb	DiseaseOsteological	BrandCalcimar	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous or Intramuscular Injection	CategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents	TargetCalcitonin receptor
ID1099	ThPPIDTh1014	NameSalmon Calcitonin	Peptide SequenceCSNLSTCVLGKLSQELHKLQ Full view	Length32	Functional ClassificationIb	DiseaseOsteological	BrandFortical	CompanyN.A.	Physical AppearanceNasal spray	Route of AdministartionIntranasal use	CategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents	TargetCalcitonin receptor
ID1100	ThPPIDTh1014	NameSalmon Calcitonin	Peptide SequenceCSNLSTCVLGKLSQELHKLQ Full view	Length32	Functional ClassificationIb	DiseaseOsteological	BrandMiacalcin	CompanyNovartis	Physical AppearanceSolution	Route of AdministartionSubcutaneous or Intramuscular Injection	CategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents	TargetCalcitonin receptor
ID1317	ThPPIDTh1044	NameAdalimumab	Peptide SequenceLight-chain:DIQMTQS< Full view	Length230	Functional ClassificationIc	DiseaseOsteological	BrandHumira Pen	CompanyAbbott Laboratories	Physical AppearanceSterile, preservative-free solution	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents, Anti-inflammatory, Antirheumatic agents	TargetTumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm
ID1535	ThPPIDTh1114	NamePreotact	Peptide SequenceParathyroid hormone: Full view	Length84	Functional ClassificationIb	DiseaseOsteological	BrandPreotactÂÂÂ	CompanyNycomed	Physical AppearanceN.A.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetParathyroid hormone/parathyroid hormone-related peptide receptor,Parathyroid hormone 2 receptor
ID1556	ThPPIDTh1120	NameTeriparatide	Peptide SequenceParathyroid hormone Full view	Length34	Functional ClassificationIb	DiseaseOsteological	BrandForteo	CompanyEli Lilly and Company	Physical AppearanceSterile, colorless, clear, isotonic solution	Route of AdministartionSubcutaneous injection	CategoryBone Density Conservation Agents	TargetParathyroid hormone/parathyroid hormone-related peptide receptor
ID1570	ThPPIDTh1123	NameDenosumab	Peptide SequenceHeavy chain EVQLLESG Full view	Length664	Functional ClassificationIIIc	DiseaseOsteological	BrandXgeva	CompanyAmgen.	Physical AppearanceSterile, preservative-free, clear, colorless to pale yellow solution	Route of AdministartionN.A.	CategoryBone Density Conservation Agents and Monoclonal antibodies	TargetTumor necrosis factor ligand superfamily member 11
ID1571	ThPPIDTh1123	NameDenosumab	Peptide SequenceHeavy chain EVQLLESG Full view	Length664	Functional ClassificationIIIc	DiseaseOsteological	BrandProlia	CompanyAmgen.	Physical AppearanceSterile, preservative-free, clear, colorless to pale yellow solution	Route of AdministartionN.A.	CategoryBone Density Conservation Agents and Monoclonal antibodies	TargetTumor necrosis factor ligand superfamily member 11
ID1704	ThPPIDTh1168	NameAutologous cultured chondrocytes	Peptide SequenceNA Full view	Length0	Functional ClassificationIa	DiseaseOsteological Disorders	BrandCarticel	CompanyGenzyme Corporation	Physical AppearanceImplant	Route of AdministartionIntra-auricular	CategoryNA	TargetNA
ID1845	ThPPIDTh1233	NamePegloticase	Peptide SequenceTYKKNDEVEFVRTGYGKDMI Full view	Length298	Functional ClassificationIb	DiseaseOsteological Disorders	BrandPegloticase (Krystexxa)	CompanyNA	Physical AppearanceSolid	Route of AdministartionIntravenous	CategoryEnzymes	TargetUric acid